United States · FDA National Drug Code directory
Sandostatin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0078-0180_3f1a424d-05a3-40d6-8127-44948e411611
- Product NDC
- 0078-0180
- Form
- INJECTION, SOLUTION
- Composition / generic term
- octreotide acetate
- Labeler
- Novartis Pharmaceuticals Corporation
- Marketing category
- NDA
- Marketing start / end (source format)
- 19881021
- Source listing expiry
- 20271231
Source-listed ingredients
- OCTREOTIDE ACETATE — 50 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 10 AMPULE in 1 PACKAGE (0078-0180-01) / 1 mL in 1 AMPULE (0078-0180-61) · 0078-0180-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →